Literature DB >> 15627947

Relapse of herpes encephalitis after acyclovir therapy: report of two new cases and review of the literature.

I Valencia1, D K Miles, J Melvin, D Khurana, S Kothare, H Hardison, A Legido.   

Abstract

Relapse of herpes simplex virus (HSV) encephalitis following acyclovir therapy has been reported infrequently in children beyond the neonatal period. The pathogenic mechanism of the recurrence is not fully understood. We report two new cases that support a mechanism of latent HSV infection with reactivation of the disease. Our patients were 2 years (#1) and 8 months (#2) old at initial infection. Both presented with fever, lethargy, focal seizures, and focal motor abnormalities. Serum HSV antibodies (Abs) were negative. The patients were treated with acyclovir for 14 and 21 days, respectively. They were readmitted at 1 month, and 4 days after discharge, respectively, with recurrent lethargy, seizures, and choreo-athetoid movements. Serum and CSF HSV Abs were significantly increased. CSF PCR was positive. In patient # 2 acyclovir-sensitive HSV was isolated from a brain biopsy. Both patients were re-treated with acyclovir, but progressed to a neurovegetative state. In our cases, latent HSV infection and reactivation is the most likely explanation for recurrent encephalitis. The immuno-pathogenic mechanisms of the infection recurrence are discussed. Based on the reported cases in the literature, patients younger than 2 years of age and with lower total dose of acyclovir treatments have a higher risk of recurrence.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15627947     DOI: 10.1055/s-2004-830372

Source DB:  PubMed          Journal:  Neuropediatrics        ISSN: 0174-304X            Impact factor:   1.947


  16 in total

Review 1.  NMDAR Encephalitis Following Herpes Simplex Virus Encephalitis.

Authors:  Jonathan Galli; Stacey L Clardy; Amanda L Piquet
Journal:  Curr Infect Dis Rep       Date:  2017-01       Impact factor: 3.725

2.  HSV encephalitis-induced anti-NMDAR encephalitis in a 67-year-old woman: report of a case and review of the literature.

Authors:  Nicholas A Morris; Tamara B Kaplan; Jenny Linnoila; Tracey Cho
Journal:  J Neurovirol       Date:  2015-07-03       Impact factor: 2.643

Review 3.  Seizures and epilepsy in herpes simplex virus encephalitis: current concepts and future directions of pathogenesis and management.

Authors:  Johann Sellner; Eugen Trinka
Journal:  J Neurol       Date:  2012-04-18       Impact factor: 4.849

4.  Antiviral selection in the management of acute retinal necrosis.

Authors:  Patrick M K Tam; Claire Y Hooper; Susan Lightman
Journal:  Clin Ophthalmol       Date:  2010-02-02

5.  Innate defense mechanisms against HSV-1 infection in the target tissues, skin and brain.

Authors:  Yael Tsalenchuck; Israel Steiner; Amos Panet
Journal:  J Neurovirol       Date:  2016-04-20       Impact factor: 2.643

6.  Prolonged microglial cell activation and lymphocyte infiltration following experimental herpes encephalitis.

Authors:  Cristina P Marques; Maxim C-J Cheeran; Joseph M Palmquist; Shuxian Hu; Stina L Urban; James R Lokensgard
Journal:  J Immunol       Date:  2008-11-01       Impact factor: 5.422

7.  TLR3 deficiency in herpes simplex encephalitis: high allelic heterogeneity and recurrence risk.

Authors:  Hye Kyung Lim; Mikko Seppänen; Timo Hautala; Michael J Ciancanelli; Yuval Itan; Fabien G Lafaille; William Dell; Lazaro Lorenzo; Minji Byun; Elodie Pauwels; Ylva Rönnelid; Xin Cai; Soraya Boucherit; Emmanuelle Jouanguy; Anders Paetau; Pierre Lebon; Flore Rozenberg; Marc Tardieu; Laurent Abel; Alisan Yildiran; Anne Vergison; Reina Roivainen; Amos Etzioni; Pentti J Tienari; Jean-Laurent Casanova; Shen-Ying Zhang
Journal:  Neurology       Date:  2014-10-22       Impact factor: 9.910

8.  Infantile nonconvulsive status epilepticus caused by herpes encephalitis.

Authors:  Gulnar Sensoy; Tulin Revide Sayli; Alev Guven; Gozde Kanmaz
Journal:  J Pediatr Neurosci       Date:  2009-07

Review 9.  Antiviral drugs for viruses other than human immunodeficiency virus.

Authors:  Raymund R Razonable
Journal:  Mayo Clin Proc       Date:  2011-10       Impact factor: 7.616

10.  Herpes simplex virus encephalitis in a patient with complete TLR3 deficiency: TLR3 is otherwise redundant in protective immunity.

Authors:  Yiqi Guo; Magali Audry; Michael Ciancanelli; Laia Alsina; Joana Azevedo; Melina Herman; Esperanza Anguiano; Vanessa Sancho-Shimizu; Lazaro Lorenzo; Elodie Pauwels; Paul Bastard Philippe; Rebeca Pérez de Diego; Annabelle Cardon; Guillaume Vogt; Capucine Picard; Zafitsara Zo Andrianirina; Flore Rozenberg; Pierre Lebon; Sabine Plancoulaine; Marc Tardieu; Emmanuelle Jouanguy; Damien Chaussabel; Frederic Geissmann; Laurent Abel; Jean-Laurent Casanova; Shen-Ying Zhang
Journal:  J Exp Med       Date:  2011-09-12       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.